Tumor growth of rechallenged glioblastoma in the mice treated before (IMAGE)

Innovation Center of NanoMedicine

Tumor growth of rechallenged glioblastoma in the mice treated before

Caption

80% of the mice pre-treated with glucose-PEGylated avelumab rejected the growth of rechallenged glioblastoma.

Credit

2021 Innovation Center of NanoMedicine

Usage Restrictions

All rights reserved

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.